How Good Are Free Ransomware Decryptors?

In the light of recent months, with the cases continuously climbing high during the current pandemic, many companies and their customers have been facing numerous ransomware and hijacking attempts – from robotext messages, robocalls, and virus injections. Hackers are really leaning hard on ransomware because it gives them an edge over the customers – lock their data, and if you pay the ransom, we’ll give you a solution, and you can decrypt your files! One such ransomware virus that took the world by storm was the ThiefQuest (a.k.a. EvilQuest) ransomware virus. But one company decided to break that cycle by offering a way that people can decrypt their data for free: the one and only SentinelOne.

Recommended article: SentinelOne is #1 at Crushing Viruses and Keeping You Safe

Mac Users Are the Targets
Unlike the other numerous viruses that target Windows users, the specific EvilQuest ransomware targets Mac operators. However, the downside to this is that many businesses are the primary users of Mac computers, laptops, and products. As a matter of fact, there are more iPhone users in the world that use the MacOS on their mobile platforms and office computers than Windows users. Either way, the virus is meant to decrypt files, and it does not tell infected users how to contact the company. It does provide a Bitcoin wallet and where to deposit your ransom to. And they only give you 72 hours to get your ransom to them.

The Free Decryptor
There are many other ransomware programs out there, and SentinelOne is one of those companies who have been able to say they’re coming to the call. Most users who get infected with ransomware don’t get their files restored with this virus, and they are permanently locked out of them. The decryption process that SentinelOne provides is that their researchers basically recreated the virus and then reverse-engineered it. They were able to analyze the code pattern and decipher the malicious code that’s injected into the files so they can remove it. Fortunately, it’s because the ransomware itself is rather new (meaning that it was very recently created – so it has some bugs). Other ransomware viruses are a bit harder to crack. But does it work?

Recommended article: How Quickly a Ransomware Attack Can Happen In 2020

According to SentinelOne, it does. And so, do many others. Of course, they do have disclaimers in case they can’t decrypt literally every single file. That’s because there is no guarantee that every virus is different. One virus, though, that’s being used a lot is the WannaCry ransomware on PC’s ranging from small businesses all the way up to government officials (and one of the most common during these times). Having a good product such as SentinelOne, or even getting the Trend Micro tool can help. There is a good chance that you may not actually need to pay the fee to get your files unlocked. However, some of the more advanced viruses may have numerous variants in code, so it may not be easy to pinpoint which one it is and the code (which may sometimes be randomly inserted into a file) itself. Therefore, you need to have a good protection plan in place.

What Should I Do?
If you get ahold of your local IT support team, they’ll be able to help you get some of the best security tools and can even provide local and cloud-based backups of your precious data in case of a ransomware attack. Many companies have been able to say that their ransomware hiccups have cost them, but most of them are paying their hackers not to leak their customers’ data. Don’t be that person, and keep your data safe, and you’ll be much better off in the long run!

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

Pay Attention to Skin Care Products Ingredients

Did you know that some skin care products are actually classified as drugs not cosmetics? Some skin care ingredients can actually change the structure of skin which may be more than you originally bargained for.In order to protect your skin it’s important that you pay attention to ingredient labels. Some skin care products are laced with harmful chemicals that can actually damage your skin The problem is that finding out whether or not a product will harm your skin takes a bit of investigative work.Those skin care products that claim to reduce lines, change wrinkles, or alter your face in any manner may be doing a lot of damage. Various products are actually considered a drug by the government for the sheer fact that they contain lots of harsh chemicals.Even more frightening than the fact that some skin care products may actually ruin your skin is the fact that some products aren’t even considered drugs…even though they have skin altering ingredients. These products are often called “cosmeceutical” products within the skin care world.Cosmeceutical products actually change the biological makeup of the skin In short, these products will do a lot more than change the look of your skin ..they will actually change your skin’s elasticity. If you don’t want to apply products that can damage your skin it is best to purchase on natural skin products.Skin care can be quite complex given the fact that there are so many conflicting points of view out there. Some people will tell you to purchase products that contain chemicals, while other people are against any kind of chemical skin care product. So, what are you supposed to do?You can begin by searching for skin care products that only contain ingredients you can pronounce. This may seem silly, but if you can’t actually say the names of the ingredients inside of a product, you shouldn’t be putting that product on your skin.Next, make sure that you are purchasing only natural skin care products. Then again, natural means many different things within the skin care industry. Stick with those ingredients that you know, or take the time to research ingredients that you aren’t familiar with.Numerous products on the market will claim to change the way that you look. Still, many of these products don’t work…and most of them can actually ruin your skin If a product claims to alter your appearance, make sure that those chemicals won’t actually alter your skin’s structure.Skin’s elasticity is the one thing that keeps your skin from sagging and drooping. If you continuously apply a product that eats away at your skin’s elasticity, you might not be able to enjoy your skin’s natural appearance any longer. Avoid any skin care product that will potentially ruin your skin for good.Once skin loses its elasticity, it is hard to get it back. Using natural skin care products that don’t damage your skin is the best way to ensure that you will have youthful, radiant, skin for years to come. Be careful about what you put on your skin – after all, you only get one chance to treat your skin right.